Far Infrared Radiation Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Modulation of the p53/TGF-β Signaling Pathway
International Journal of Molecular Sciences · 10.03.2026 · 27 (6) · 2551
DOI: 10.3390/ijms27062551 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.03.2026. Verfasst von Jicheng Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Shandong Second Medical University, Weifang 261053, China. Hauptthemen laut MEDLINE: Bleomycin, Tumor Suppressor Protein p53, Signal Transduction, Infrared Rays. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wu Jieping Medical Foundation, Weifang University of Science and Technology.
Abstract (Originalsprache)
Currently, there is no curative medication for idiopathic pulmonary fibrosis (IPF), and therapeutic interventions for IPF are hindered by limited efficacy and severe adverse side effects. Far Infrared Radiation (FIR), an invisible form of electromagnetic energy, has garnered increasing attention for its multiple biological effects. However, its therapeutic benefits and the underlying mechanisms of IPF have not been investigated. In the present study, we established a mouse model of bleomycin-induced pulmonary fibrosis (BIPF) to assess the efficacy of FIR in attenuating BIPF. The results showed that FIR therapy significantly improved the general condition of the mice and protected pulmonary function by ameliorating lung fibrosis, collagen deposition and excessive inflammation. Moreover, FIR could alleviate fibroblast-to-myofibroblast differentiation (FMD), the epithelial–mesenchymal transition (EMT) and angiogenesis in BIPF mice. These beneficial effects were notable both in the pro-fibrotic inflammatory stage and the following fibrotic stage. Mechanistically, FIR exerted anti-inflammatory and anti-fibrotic effects through modulating the p53/TGF-β signaling pathway. Overall, this study elucidates the anti-fibrotic activity and the potential molecular mechanisms of FIR in treating BIPF, providing a therapeutic strategy of convenient, non-invasive physical therapy for alleviating IPF. Of greater significance, the findings of this study display the promising future applications of FIR in managing the physiopathology of various chronic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Shandong Second Medical University, Weifang 261053, China.
- School of Rehabilitation Medicine, Shandong Second Medical University, No. 7166, Baotong West Street, Weifang 261041, China.
- Department of Clinical Pathology, School of Basic Medicine, Shandong Second Medical University, Weifang 261053, China.
ORCID-Profile: Lihong Shi
Förderung
- Wu Jieping Medical Foundation
- Weifang University of Science and Technology
Zitieren
APA
Li, J., Chang, J., Chu, W., Jiang, Y., Sun, S., Ding, X., Zhang, L., & Shi, L. (2026). Far Infrared Radiation Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Modulation of the p53/TGF-β Signaling Pathway. International Journal of Molecular Sciences, 27(6), 2551. https://doi.org/10.3390/ijms27062551
Vancouver
Li J, Chang J, Chu W, Jiang Y, Sun S, Ding X, et al. Far Infrared Radiation Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Modulation of the p53/TGF-β Signaling Pathway. International Journal of Molecular Sciences. 2026;27(6):2551. doi:10.3390/ijms27062551
BibTeX
@article{Li2026,
author = {Li, Jicheng and Chang, Jingxu and Chu, Wenhan and Jiang, Yu and Sun, Shaodi and Ding, Xiaodi and Zhang, Liying and Shi, Lihong},
title = {Far Infrared Radiation Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Modulation of the p53/TGF-β Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2551},
doi = {10.3390/ijms27062551}
}
EUVIMED